The rising popularity in GLP-1 medications for metabolic conditions has sparked a debate about formats: transdermal systems versus tablets . Typically, GLP-1 drugs were exclusively available in oral form, but the introduction of transdermal delivery presents a alternative option . Transdermal systems might suit individuals with challenges swallowin